Rituximab and Belimumab for Lupus Nephritis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Wofsy, M.D.
University of California San Francisco, Department of Medicine
Study ChairKOL profile → - Maria Dall'Era, M.D.
University of California San Francisco, Department of Medicine
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama, Birmingham
Birmingham, Alabama, United States
- Ucla Medical Center: Division of Rheumatology
Los Angeles, California, United States
- University of California, San Francisco
San Francisco, California, United States
- University of Colorado Denver: School of Medicine: Division of Rheumatology
Aurora, Colorado, United States
- Colorado Kidney Care
Denver, Colorado, United States
- Emory University School of Medicine
Atlanta, Georgia, United States
- Washington University in St. Louis
St Louis, Missouri, United States
- Feinstein Institute, North Shore Hospital
Manhasset, New York, United States
- Columbia University Medical Center
New York, New York, United States
- New York University, Langone Medical Center
New York, New York, United States
- Weill Cornell Medical College: Hospital for Special Surgery -
New York, New York, United States
- University of North Carolina School of Medicine:
Chapel Hill, North Carolina, United States
- Ohio State University Wexner Medical Center:
Columbus, Ohio, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- University of Texas Southwestern
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Jul 2015
- Primary completion
- 12 Mar 2018
- Completion
- 8 Feb 2019
- Last update posted
- 1 Dec 2020
- Registered enrollment
- 43
- Registry id
- NCT02260934
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.